+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 121 Pages
  • March 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953475
The North America IVD In Cardiology And Neurology Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).

The US market dominated the North America IVD In Cardiology And Neurology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $8,663.4 million by 2030. The Canada market is experiencing a CAGR of 11.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2023 - 2030).



The market is a dynamic and vital segment within the broader healthcare landscape. The increasing prevalence of cardiovascular and neurological disorders has led to a significant surge in the application of IVD tests in the fields of cardiology and neurology. According to the data from the British Heart Foundation, by 2024, around 620 million individuals suffer from heart and circulatory diseases. Likewise, as per Statistics Canada, approximately 750,000 Canadians are living with Alzheimer’s disease or another form of dementia. In 2022, Alzheimer's disease constituted the ninth most prevalent cause of mortality in Canada.

In addition, these conditions often necessitate precise and early diagnosis, so integrating IVD technologies has become indispensable for healthcare providers. An important factor in the widespread adoption of IVD tests in these specialties has been the growing consciousness among clinicians and patients regarding the critical nature of early detection and proactive management of cardiac and neurological disorders.

Canada's rising aging population is likely to significantly impact the expansion of In Vitro Diagnostics (IVD) in cardiology and neurology. As individuals age, the prevalence of chronic diseases and conditions associated with these medical specialties tends to increase. IVD plays a crucial role in the diagnosis, monitoring, and management of cardiovascular and neurological disorders, making it an essential component of healthcare for the elderly population. As per Statistics Canada, in 2022, there were 7,330,605 people aged 65 and older in Canada. Moreover, over 861,000 people aged 85 and older were counted in the 2021 Census, more than twice the number observed in the 2001 Census. Hence, rising CVD cases and the aging population in North America will assist in the growth of the market.

Based on Product Type, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. Based on End Use, the market is segmented into Hospitals, Clinical Laboratories, and Others. Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Hematology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • F.Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Becton, Dickinson and Company
  • Natera, Inc.

Market Report Segmentation

By Product Type
  • Reagents & Consumables
  • Instruments
  • Software & Services
By End Use
  • Hospitals
  • Clinical Laboratories
  • Others
By Technology
  • Immunoassays
  • Molecular Diagnostics
  • Hematology
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America IVD In Cardiology And Neurology Market, by Product Type
1.4.2 North America IVD In Cardiology And Neurology Market, by End Use
1.4.3 North America IVD In Cardiology And Neurology Market, by Technology
1.4.4 North America IVD In Cardiology And Neurology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America IVD In Cardiology And Neurology Market by Product Type
4.1 North America Reagents & Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America IVD In Cardiology And Neurology Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Clinical Laboratories Market by Country
5.3 North America Others Market by Country
Chapter 6. North America IVD In Cardiology And Neurology Market by Technology
6.1 North America Immunoassays Market by Country
6.2 North America Molecular Diagnostics Market by Country
6.3 North America Hematology Market by Country
6.4 North America Others Market by Country
Chapter 7. North America IVD In Cardiology And Neurology Market by Country
7.1 US IVD In Cardiology And Neurology Market
7.1.1 US IVD In Cardiology And Neurology Market by Product Type
7.1.2 US IVD In Cardiology And Neurology Market by End-use
7.1.3 US IVD In Cardiology And Neurology Market by Technology
7.2 Canada IVD In Cardiology And Neurology Market
7.2.1 Canada IVD In Cardiology And Neurology Market by Product Type
7.2.2 Canada IVD In Cardiology And Neurology Market by End-use
7.2.3 Canada IVD In Cardiology And Neurology Market by Technology
7.3 Mexico IVD In Cardiology And Neurology Market
7.3.1 Mexico IVD In Cardiology And Neurology Market by Product Type
7.3.2 Mexico IVD In Cardiology And Neurology Market by End-use
7.3.3 Mexico IVD In Cardiology And Neurology Market by Technology
7.4 Rest of North America IVD In Cardiology And Neurology Market
7.4.1 Rest of North America IVD In Cardiology And Neurology Market by Product Type
7.4.2 Rest of North America IVD In Cardiology And Neurology Market by End-use
7.4.3 Rest of North America IVD In Cardiology And Neurology Market by Technology
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Quest Diagnostics Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.5 SWOT Analysis
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Danaher Corporation (Beckman Coulter)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Becton, Dickinson, and Company
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Becton, Dickinson and Company
  • Natera, Inc.

Methodology

Loading
LOADING...